A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis

被引:181
|
作者
Krentel, Alison [1 ,2 ]
Fischer, Peter U. [1 ]
Weil, Gary J. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
[2] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England
来源
PLOS NEGLECTED TROPICAL DISEASES | 2013年 / 7卷 / 11期
基金
比尔及梅琳达.盖茨基金会;
关键词
NEGLECTED TROPICAL DISEASES; RURAL-AREAS; WESTERN PROVINCE; ORISSA STATE; TAMIL-NADU; PROGRAM; INDIA; COMMUNITY; IMPACT; COVERAGE;
D O I
10.1371/journal.pntd.0002447
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review of factors that affect compliance with MDA. Methodology/Principal Findings: Papers published between 2000 and 2012 were considered, and 79 publications were included in the final dataset for analysis after two rounds of selection. While results varied in different settings, some common features were associated with successful programs and with compliance by individuals. Training and motivation of drug distributors is critically important, because these people directly interact with target populations, and their actions can affect MDA compliance decisions by families and individuals. Other important programmatic issues include thorough preparation of personnel, supplies, and logistics for implementation and preparation of the population for MDA. Demographic factors (age, sex, income level, and area of residence) are often associated with compliance by individuals, but compliance decisions are also affected by perceptions of the potential benefits of participation versus the risk of adverse events. Trust and information can sometimes offset fear of the unknown. While no single formula can ensure success MDA in all settings, five key ingredients were identified: engender trust, tailor programs to local conditions, take actions to minimize the impact of adverse events, promote the broader benefits of the MDA program, and directly address the issue of systematic non-compliance, which harms communities by prolonging their exposure to LF. Conclusions/Significance: This review has identified factors that promote coverage and compliance with MDA for LF elimination across countries. This information may be helpful for explaining results that do not meet expectations and for developing remedies for ailing MDA programs. Our review has also identified gaps in understanding and suggested priority areas for further research.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] LESSONS FROM MASS DRUG ADMINISTRATION FOR THE ELIMINATION OF LYMPHATIC FILARIASIS (LF) IN AN URBAN SETTING IN HAITI
    Bennett, Cudjoe
    Fayette, Carl
    Monestime, Franck
    Javel, Alain
    Miller, Lior
    Craciunoiu, Sarah
    Direny, Abdel
    Lemoine, Jean-Franze
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 155 - 155
  • [42] Bridging the gap in outreach and compliance with mass drug administration for lymphatic filariasis elimination in an endemic district in Kerala, India: an intervention research approach
    Nandha, B.
    Meenakshy, V.
    Khader, Nazer Abdul
    Vijayakumar, K. N.
    Jambulingam, P.
    HEALTH EDUCATION RESEARCH, 2019, 34 (03) : 300 - 309
  • [43] A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa
    Silumbwe, Adam
    Zulu, Joseph Mumba
    Halwindi, Hikabasa
    Jacobs, Choolwe
    Zgambo, Jessy
    Dambe, Rosalia
    Chola, Mumbi
    Chongwe, Gershom
    Michelo, Charles
    BMC PUBLIC HEALTH, 2017, 17
  • [44] A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa
    Adam Silumbwe
    Joseph Mumba Zulu
    Hikabasa Halwindi
    Choolwe Jacobs
    Jessy Zgambo
    Rosalia Dambe
    Mumbi Chola
    Gershom Chongwe
    Charles Michelo
    BMC Public Health, 17
  • [46] Mass Drug Administration (MDA) for Elimination of Lymphatic Filariasis: Experiences from Nayagarh District of Odisha, India
    Bhatia, Vikas
    Giri, Prajna Paramita
    Sahoo, Soumya Swaroop
    Preeti, P. S.
    Sahu, Dinesh Prasad
    INDIAN JOURNAL OF COMMUNITY HEALTH, 2018, 30 (03) : 287 - 292
  • [47] Mass drug administration to eliminate lymphatic filariasis in Southern India
    Pattanshetty, Sanjay
    Kumar, Ashwini
    Kumar, Ravi
    Rao, Chythra R.
    Badiger, Sanjeev
    Rashmi, R.
    Kamath, Sneha
    AUSTRALASIAN MEDICAL JOURNAL, 2010, 3 (13): : 847 - 850
  • [48] Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review
    Halim, Ahmad Farid Nazmi Abdul
    Ahmad, Dzulfitree
    Yn, Jane Ling Miaw
    Masdor, Noor Azreen
    Ramly, Nurfatehar
    Othman, Rahayu
    Kandayah, Thinakaran
    Hassan, Mohd Rohaizat
    Dapari, Rahmat
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [49] A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India
    Kumar, Ashwini
    Kumar, Pawan
    Nagaraj, Kondagunta
    Nayak, Divakar
    Ashok, Lena
    Ashok, K.
    JOURNAL OF VECTOR BORNE DISEASES, 2009, 46 (03) : 237 - 240
  • [50] Knowledge and Practice Related to Compliance with Mass Drug Administration during the Egyptian National Filariasis Elimination Program
    Abd Elaziz, Khaled M.
    El-Setouhy, Maged
    Bradley, Mark H.
    Ramzy, Reda M. R.
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (02): : 260 - 264